Faster MRI scans to monitor ovarian cancer recurrence
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a quicker MRI method to watch for ovarian cancer returning in people taking PARP-inhibitor maintenance therapy. It may help doctors find recurrence earlier, making surgery more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of ovarian cancer called high-grade serous ovarian cancer
- Your cancer is BRCA wild-type and HRP (meaning your tumor does not have certain genetic mutations)
- You had no tumor left after your first surgery to remove the cancer
- It has been more than 6 months since your last platinum-based chemotherapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses two types of PET/CT scans (68Ga-FAPI-46 and 18F-FDG) to look for any returning ovarian cancer. The goal is to find recurrence early so you and your doctor can plan the next steps.
This trial tests whether olaparib (a pill cancer medicine) works better than standard platinum chemotherapy after a second surgery for recurrent ovarian cancer. It’s for people whose cancer returned after initial PARP-inhibitor (PARPi) maintenance and aims to see if treatment can control the cancer for longer with acceptable side effects.
This study looks for specific gene mutations in the blood of ovarian cancer patients who have a BRCA mutation and are starting first-line maintenance therapy with a PARP inhibitor called Olaparib. It aims to better understand how these mutations may affect treatment response.
This trial tests whether doing additional (“secondary”) tumor-removal surgery can help people with ovarian, fallopian tube, or primary peritoneal cancer that has returned after PARP inhibitor maintenance. It focuses on people whose cancer can likely be fully removed and who are considered good candidates for surgery and follow-up treatment.
This trial checks whether having surgery to remove as much tumor as possible, followed by ongoing targeted treatment, helps people with advanced ovarian (and related) cancers live longer and/or control cancer better. It specifically uses tumor-testing results to match patients and then continues treatment after surgery.
This study aims to develop better laboratory models of ovarian cancer that does not respond to treatment. This could help doctors understand why some cancers resist therapy and find new ways to treat them. Participation may involve providing tissue samples or other data for research.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.